What makes ICON Public Limited Company (ICLR) an Attractive Investment?
Invesco Distributors, Inc., an investment management firm, released its “Invesco Small Cap Value Fund” fourth quarter 2024 ...
Class Action Filed Against ICON Public Limited Company (ICLR) Seeking Recovery for Investors - Contact Levi & Korsinsky
NEW YORK, NY / ACCESS Newswire / March 13, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to ...
Insiders at Irish-based Icon had motive to sell €74m shares at ‘artificially inflated price’, US lawsuit claims
Company says it will ‘vigorously’ defend class action suit alleging it made ‘materially false and misleading’ statements on performance ...
ICON Public Limited Company (ICLR): A Bull Case Theory
We came across a bullish thesis on ICON Public Limited Company (ICLR) on Substack by Oliver | MMMT Wealth. In this article, ...
Seeking Alpha7d
ICLR ICON Public Limited Company
The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is ...
Morningstar21d
Narrow-Moat Icons Faces Macroeconomic Challenges in Near Term; Positive Long-Term Outlook
As an Irish company, Icon benefits from a lower tax rate than many of its peers based in the United States. Drawbacks to biotech funding or declines in outsourcing penetration rates could have a ...
CNN16d
A little-known Chinese company made a drug that beat the world’s biggest-selling medicine
In September, Akeso, a little-known Chinese biotech company founded nearly a decade ago shook up the biotech sector with its new lung cancer drug. Ivonescimab, the new drug, was found in a trial ...